AI Health Technology Limited (HKG:1715)

AI Health Technology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	50.51	27.07	2.3	33.95	11.36	32.35
Cash & Short-Term Investments	50.51	27.07	2.3	33.95	11.36	32.35
Cash Growth	9.96%	1077.64%	-93.23%	198.97%	-64.89%	-32.87%
Accounts Receivable	4.7	6.23	24.65	18.41	13.3	31.49
Other Receivables	15.17	57.11	6.11	20.96	5.79	0.68
Receivables	19.87	63.34	30.76	39.37	19.1	32.17
Inventory	12.96	17.48	30.71	50.18	84.13	64.82
Other Current Assets	1.34	16.8	54.04	11.59	52.88	21.5
Total Current Assets	84.67	124.69	117.81	135.08	167.46	150.84
Property, Plant & Equipment	9.23	10.18	10.18	14.35	16.24	22.4
Long-Term Investments	-	0.14	1.17	7.67	1.22	7.35
Other Intangible Assets	7.68	7.82	8.1	8.43	8.82	9.3
Long-Term Deferred Tax Assets	-	-	-	-	-	0.08
Other Long-Term Assets	2.27	3.85	0.21	0.21	0.06	0.75
Total Assets	103.86	146.69	137.47	165.74	193.8	190.72

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	14.86	17.29	12.71	11.35	15.84	16.17
Accrued Expenses	-	-	-	-	-	5.46
Current Portion of Long-Term Debt	35.41	41.93	54.22	64.99	74.26	23.63
Current Portion of Leases	-	-	0.25	1.32	1.22	2.96
Current Income Taxes Payable	0.21	0.42	0.42	0.42	0.45	0.45
Current Unearned Revenue	4.71	6.13	1.47	1.36	2.78	3.42
Other Current Liabilities	4.69	16.61	19.42	22.74	14.65	8.16
Total Current Liabilities	59.87	82.38	88.49	102.17	109.19	60.25
Long-Term Debt	4.09	4.27	6.27	4.51	4.38	5.05
Long-Term Leases	-	-	-	0.58	0.06	1.28
Long-Term Deferred Tax Liabilities	0.41	0.38	0.32	0.28	0.26	-
Total Liabilities	64.36	87.02	95.08	107.53	113.9	66.58

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.32	0.32	25.76	16.11	12.56	12.56
Additional Paid-In Capital	102.84	102.84	106.79	96.22	72.17	72.17
Retained Earnings	-	-89.73	-135.11	-99.26	-49.94	-6.73
Comprehensive Income & Other	-64.5	45.38	44.62	45.14	45.57	46.26
Total Common Equity	38.65	58.8	42.06	58.21	80.36	124.27
Minority Interest	0.84	0.86	0.34	-	-0.46	-0.12
Shareholders' Equity	39.49	59.66	42.39	58.21	79.91	124.15
Total Liabilities & Equity	103.86	146.69	137.47	165.74	193.8	190.72

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	39.5	46.2	60.74	71.4	79.93	32.92
Net Cash (Debt)	11.02	-19.12	-58.44	-37.45	-68.57	-0.57
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	0.03	-0.07	-0.60	-0.55	-1.14	-0.01
Filing Date Shares Outstanding	360.76	360.76	117.92	75.61	60	60
Total Common Shares Outstanding	360.76	360.76	117.92	75.61	60	60
Working Capital	24.81	42.31	29.33	32.91	58.27	90.6
Book Value Per Share	0.11	0.16	0.36	0.77	1.34	2.07
Tangible Book Value	30.97	50.98	33.96	49.78	71.54	114.97
Tangible Book Value Per Share	0.09	0.14	0.29	0.66	1.19	1.92
Buildings	-	14.86	14.86	14.86	14.86	14.86
Machinery	-	8.87	6.7	7	7.23	9.9
Leasehold Improvements	-	15.58	15.58	15.56	15.56	15.02

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 1, 2026

Data Sources Report a data error